The term Dtl Activators would refer to a class of chemical compounds that selectively interact with and increase the activity of Dtl, which is an abbreviation for denticleless E3 ubiquitin protein ligase homolog. Dtl is a protein that has been identified as part of the ubiquitin-proteasome system, a critical pathway for protein degradation in cells. In this context, activators of Dtl would be molecules that enhance its E3 ligase function, potentially by promoting its interaction with substrate proteins, facilitating the transfer of ubiquitin from E2 enzymes to substrates, or stabilizing the active conformation of the Dtl protein. These compounds could be designed based on the structural and functional understanding of the Dtl protein and could range from small molecules to biologically derived entities like peptides or peptidomimetics. The chemistry of Dtl activators would be centered around their ability to bind to the protein, potentially affecting its conformational dynamics to stimulate its ligase activity.
In the study and development of Dtl activators, extensive research tools and techniques would be employed to identify and optimize these compounds. High-throughput screening assays could be used to sift through large libraries of chemicals to find candidates that increase the activity of Dtl. Such screenings would rely on assays capable of detecting the post-translational modification of proteins by ubiquitination, a hallmark of the protein degradation pathway mediated by E3 ligases like Dtl. Following the identification of potential activators, detailed biochemical characterization would be essential to determine their mode of action. This might include kinetic analyses to measure the effect of the activators on the catalytic efficiency of Dtl, as well as binding studies using techniques like fluorescence quenching or isothermal titration calorimetry to elucidate the affinity and stoichiometry of the interaction. Complementary to these functional assays, structural studies using X-ray crystallography or NMR spectroscopy could provide insight into the molecular interactions between Dtl and its activators, revealing how these compounds achieve their modulatory effects. These approaches would collectively advance understanding of the activator compounds and their interaction with the Dtl protein, expanding knowledge of the regulation of the ubiquitin-proteasome system.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Hydroxyurea causes replication stress, which can activate DNA damage response and potentially upregulate Dtl expression for maintaining genomic stability. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide induces DNA damage and can lead to activation of DNA repair pathways, potentially increasing Dtl expression as part of the response mechanism. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
As an antimetabolite, 5-Fluorouracil interferes with DNA replication, potentially leading to upregulation of Dtl in a compensatory response to DNA damage. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin causes DNA crosslinking and damage, which may stimulate the DNA damage response and upregulate Dtl as a part of this process. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin intercalates into DNA, causing damage that might enhance the expression of Dtl through activation of DNA repair mechanisms. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, leading to DNA synthesis inhibition and potential compensatory upregulation of Dtl. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits topoisomerase I, leading to DNA breaks and possible induction of Dtl expression as part of the cellular stress response. | ||||||
Atrazine | 1912-24-9 | sc-210846 | 5 g | $165.00 | 1 | |
Atrazine is an herbicide that causes oxidative stress, which might lead to an increase in Dtl expression as a protective cellular response. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $87.00 $224.00 | ||
Arsenic exposure can lead to cellular stress and DNA damage, potentially inducing Dtl expression for genome maintenance. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide has been shown to affect multiple cellular processes, including gene expression, potentially influencing Dtl levels. |